Functional disruption of macrophage migration inhibitory factor (MIF) suppresses proliferation of human H460 lung cancer cells by caspase-dependent apoptosis.
Functional disruption of macrophage migration inhibitory factor (MIF) suppresses proliferation of human H460 lung cancer cells by caspase-dependent apoptosis.
复制标题
DOI:
10.1186/1475-2867-13-28
复制
发表时间:
2013-03-24
影响因子:
5.8
通讯作者:
Wang D
中科院分区:
文献类型:
--
作者:
Guo Y;Hou J;Luo Y;Wang D
Macrophage migration inhibitory factor (MIF) is important in regulating cell proliferation and apoptosis in both normal and cancerous cells, and may be important in cancer progression and metastasis. In human non-small cell lung cancer (NSCLC), the underlying mechanisms responsible for MIF-dependent regulation of cellular proliferation, and cell death remain poorly appreciated. The human H460 lung cancer cell-line was treated with an optimally determined dose of 50 pmol/ml MIF siRNA, following which cell proliferation, cell cycle and apoptosis were analyzed. Additionally, known pathways of apoptosis including expression of Annexin-V, enhanced production of caspases-3 and −4 and expression of the Akt signaling protein were assessed in an attempt to provide insights into the signaling pathways involved in apoptosis following disruption of MIF expression. Specific siRNA sequences markedly decreased MIF expression in H460 cells by 2 to 5-fold as compared with the negative control. Moreover, MIF miRNA dampened not only cellular proliferation, but increased the frequency of apoptotic cells as assessed by cell-surface Annexin-V expression. Entry of cells into apoptosis was partly dependent on enhanced production of caspases −3 and −4 while not affecting the expression of either caspase-8 or the Akt signaling pathway. In a model of NSCLC, knockdown of MIF mRNA expression dampened H460 proliferation by mechanisms partly dependent on entry of cells into apoptosis and enhanced production of caspase-3 and −4. MIF expression may thus be important in NSCLC progression. Targeting MIF may have clinical utility in the management of human lung cancer.
登录
查看更多内容
DOI:
10.1084/jem.190.10.1375
发表时间:
1999-11-15
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Hudson JD;Shoaibi MA;Maestro R;Carnero A;Hannon GJ;Beach DH
通讯作者:
Beach DH
影响因子:
7.8
作者:
Hitomi, Junichi;Katayama, Taiichi;Eguchi, Yutaka;Kudo, Takashi;Taniguchi, Manabu;Koyama, Yoshihisa;Manabe, Takayuki;Yamagishi, Satoru;Bando, Yoshio;Imaizumi, Kazunori;Tsujimoto, Yoshihide;Tohyama, Masaya
通讯作者:
Tohyama, Masaya
影响因子:
7.3
作者:
Lai, KN;Leung, JCK;Lan, HY
通讯作者:
Lan, HY
DOI:
10.1073/pnas.0701553104
发表时间:
2007-08-14
影响因子:
11.1
作者:
Binsky, Inbal;Haran, Michal;Shachar, Idit
通讯作者:
Shachar, Idit
影响因子:
32.4
作者:
Bucala, Richard;Donnelly, Seamas C.
通讯作者:
Donnelly, Seamas C.